Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease.
Hepatol Commun
; 6(12): 3433-3442, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36281979
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Alcoholism
/
Liver Diseases
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Hepatol Commun
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United States